MedTrace Logo

Evaluation of Neuroma Perfusion with Indocyanine Green Fluorescence Angiography

NCT06164392 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2025-01-01

No results posted yet for this study

Summary

The purpose of this study is to characterize the perfusion of neuromas using indocyanine green fluorescence angiography

Conditions

  • Neuroma
  • Neuroma Amputation
  • Neuroma of Upper Limb
  • Neuroma of Lower Limb

Interventions

DRUG

Indocyanine green

Intravenous administration of indocyanine green followed by fluorescence angiography imaging of the neuroma

Sponsors & Collaborators

Principal Investigators

  • Gregory A Dumanian, MD · Northwestern University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-28
Primary Completion
2024-12-28
Completion
2024-12-28
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06164392 on ClinicalTrials.gov